ACME Capital

ACME Capital is a conviction-driven deep-tech venture firm that backs founders building ahead of market consensus at major platform shifts. It is strongest from Seed through Series B, especially in technically ambitious companies that can translate hard science or frontier engineering into production systems, enterprise deployments, and scalable market positions.

Evaluation weights

How much weight this investor places on each dimension. Totals 100%.

Team-led · 31%

Metrics

13%

Revenue, growth, and unit economics

Market

30%

Size, timing, and competitive landscape

Team

31%

Founder experience and execution ability

Product

26%

Differentiation and technical quality

Non-consensus bets over consensus themes
Hard traction over vanity metrics
Systems and infrastructure plays over lightweight apps
Founders who can execute through complexity over pure visionaries

Pitch difficulty

How hard it is to get a meeting and close funding from this investor.

Funded / yr

Deals closed in a typical year.

Led / yr

Rounds led in the last 12 months.

Pitches / yr

~1150

Decks reviewed in a typical year.

Acceptance rate

0.70%

Share of pitches that get funded.

Estimated — public data is not fully disclosed.

Why it's hard

Strong bias toward deep-tech and platform-shift companies excludes most conventional software startups
Requires decisive, technically credible founders who can execute in complex markets
Looks for hard proof points like backlog, pilots, or deployments rather than narrative alone
Avoids incremental or weakly differentiated businesses even in popular categories

ACME is open to backing ambitious frontier companies early, but it is highly discriminating about founder quality, real technical differentiation, and evidence that the company can survive complex operational or regulatory environments. Its preference for non-consensus, category-defining businesses narrows fit significantly even though it invests across multiple stages.

Green flags

What drives a yes for this investor.

Technically ambitious founders with decisive execution and clear ownership of hard problems
A company positioned at a real platform shift before broader market consensus forms
Evidence of real-world traction such as contracted backlog, enterprise pilots, or production deployments
Defensible systems-level advantage through vertical integration, proprietary tech, or difficult execution
A credible path to scaling into a large transformative market with plausible strategic or public exit routes

Red flags

What kills deals and gets a fast no.

Incremental me-too software pitches with little true differentiation
Reliance on hype metrics instead of evidence of real customer adoption
Founders who underestimate regulation, manufacturing, procurement, or deployment complexity
Weak or unclear route to building a large business in a transformative market
No plausible strategic or public exit pathway despite high capital intensity

How to win

Patterns that lead to successful pitches.

Frame the company as a platform-shift winner, not a feature-layer startup
Show concrete proof of traction through contracts, pilots, deployments, or procurement progress
Demonstrate why the team is uniquely equipped to navigate technical and operational complexity
Highlight defensibility through vertical integration, proprietary tech, or systems control points
Present a credible path to scale and a realistic long-term exit outcome

Fund strategy & identity

Who they are and how they operate.

Primarily invests from Seed to Series B while supporting companies from Pre-Seed through Growth
Leads a high share of early-stage rounds and writes concentrated initial checks
Uses opportunity fund capital and SPVs to double down on breakout companies
Focuses on U.S. companies with a selective allocation to Europe
Prefers category-defining systems businesses over incremental point solutions

Firm identity

Deep-tech and platform-shift oriented Off-Broadway, non-consensus investor Execution-heavy and founder-conviction driven Comfortable with technical, regulatory, and operational complexity Able to lead early rounds and concentrate capital behind winners

Investment focus

Industries, themes, and typical ARR expectations.

Industries

Artificial IntelligenceEnterprise SoftwareHealthcareSemiconductorsAerospace & DefenseIndustrial SystemsAdvanced ManufacturingSpace Technology

Investment themes

Physical AI and industrial automation systemsEnterprise Intelligence and AI-native operating softwareFrontier Health infrastructure and clinical operations platformsNext-generation compute including quantum, analog, RF, and enabling componentsAerospace, defense, and dual-use systemsAdvanced manufacturing and vertically integrated industrial systems

Typical check by stage

Pre Seed$0.5M-$1M

Seed$1M-$7M

Series A$5M-$10M

Series B$8M-$20M

Series C$5M-$15M

Growth$10M-$50M+

Typical ARR by stage

Pre Seednot disclosed

Seednot disclosed

Series Anot disclosed

Series Bnot disclosed

Series Cnot disclosed

Growthnot disclosed

Investment thesis

Core beliefs and strategy behind their investing approach.

ACME Capital backs deep‑tech founders who are building ahead of market consensus in sectors undergoing platform shifts. Its taxonomy spans Physical AI, Enterprise Intelligence, Frontier Health, Next‑Gen Compute, Aerospace & Defense, and Industrial Systems, translating to AI‑native systems, quantum and analog compute, space and defense hardware, advanced manufacturing, and AI‑enabled health infrastructure. The firm concentrates on Seed to Series B investments in the United States with up to 25 % of capital allocated to European companies, and it can follow winners via an opportunity fund and SPVs. ACME avoids consensus, incremental plays in saturated categories and seeks companies that can move from lab‑validated breakthroughs to real‑world scaled systems. Its core belief is that value is created by teams positioned at technological discontinuities—platform shifts—who pair deep technical capability with decisive execution and distribution.

Decision patterns

How they evaluate and make investment decisions.

ACME Capital invests in founders who are technically ambitious and can execute decisively, especially when their business sits at the edge of a platform‑shift tailwind that most others consider off‑Broadway. The firm looks for vertical integration, hard‑won early traction such as contracted backlogs, enterprise pilots, or production deployments, rather than vanity metrics. Team and execution are weighted heavily, but a credible path to scale within a large, transformative market is required. Deal‑breakers include me‑too incremental software plays lacking defensibility, teams unable to navigate complex regulatory or operational environments, and founders without a clear exit pathway.

Risk appetite

ACME Capital is moderately aggressive and conviction‑driven. It leads roughly 80 % of its early‑stage rounds with $5‑$10 M initial checks and often doubles down on follow‑on investments. The firm is comfortable with high technical and regulatory risk in sectors such as defense, aerospace, next‑gen compute, and frontier health, provided founders can demonstrate verifiable traction like contracts or deployments. Its two‑fund structure (an early‑stage core and an opportunity vehicle) and use of SPVs show a willingness to concentrate capital behind winners while remaining disciplined about outcomes.

Notable investments

Key portfolio companies and why they fit the thesis.

Arya HealthLead
Modular AI agents for healthcare operations match ACME's AI‑enabled frontier health thesis and early‑stage leadership focus.
CanopyLead
Connected safety and location intelligence for health systems aligns with ACME's industrial/enterprise intelligence and platform‑shift thesis.
TreonLead
AI‑native maintenance orchestration for industrial assets fits ACME's physical AI and next‑gen manufacturing focus.
LaurelLead
Time‑automation AI for professional services bridges physical/enterprise intelligence and workflow automation, aligning with ACME’s thesis.
RegologyLead
AI‑enabled regulatory intelligence platform fits ACME's enterprise software and applied AI investment area.
SoLo FundsLead
Fintech platform innovation matches ACME's business‑model disruption and consumer/financial services focus.
BraintrustLead
Web3‑enabled talent marketplace represents a platform‑shift and business‑model innovation that ACME targets.

Key people

Partners who lead investments and shape the thesis.

SS
Scott Stanford
Co-Founder and Partner
deep techAIenterprise connectivitytechnology operations
HN
Hany Nada
Co-Founder and Partner
deep techsoftwareAI/MLconsumerhealthfintech
AF
Alex Fayette
Partner
frontier techaerospace & defensenext-gen computetech biophysical AIenergyraw materials
AH
Aike Ho
Partner
digital healthconsumerfintechearly-stage frontier tech
CT
Christian Tang-Jespersen
Partner
growth-stage technologyindustrial/deep techglobal scaling

Public voice

Notable statements and public positions.

We back deep‑tech founders who pair technical ambition with decisive execution. We partner the same way. Through every phase, we show up with conviction, craft, and a bias toward forward motion.
The first call when there’s no playbook. If we wouldn’t make a founder’s memoir, we’re not doing our job.
the team has focused on a wide variety of startups in what Stanford calls their off‑Broadway strategy.

Similar investors

Firms with overlapping stage and industry focus.

Coatue 0.8%

Shared focus

Artificial IntelligenceEnterprise SoftwareSemiconductors

6 shared stages

Mayfield Fund 0.4%

Shared focus

Artificial IntelligenceEnterprise SoftwareSemiconductors

6 shared stages

Google Ventures 0.0%

Shared focus

Artificial IntelligenceEnterprise SoftwareHealthcare

6 shared stages

General Catalyst 0.9%

Shared focus

Artificial IntelligenceHealthcare

6 shared stages